![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Impax Introduces Oxymorphone Hydrochloride Extended-Release Tablets
Impax Introduces Oxymorphone Hydrochloride Extended-Release Tablets
January 4, 2013
Impax Laboratories said it is commencing shipment of oxymorphone hydrochloride extended-release tablets via Global Pharmaceuticals, Impax’s generics unit.
RTTNews
RTTNews
Upcoming Events
-
21Oct